$DCTH 4 SEC Filings

Filed On	Filing
14 Oct 2026	Form 4: Rosalind Advisors, Inc., Director and 2 others Received 3,627 shares by conversion · Disposed of 27,502 shares (Other Transaction)
14 May 2026	Form 4: Sylvester John Richard, Director Granted 22,500 Stock Option (right to buy)
14 May 2026	Form 4: Martell Bridget A, Director Granted 22,500 Stock Option (right to buy)
14 May 2026	Form 4: Czerepak Elizabeth, Director Granted 22,500 Stock Option (right to buy)
14 May 2026	Form 4: Salamon Steven A J, Director Granted 22,500 Stock Option (right to buy)
14 May 2026	Form 4: Aharon Gil, Director Granted 22,500 Stock Option (right to buy)
06 Mar 2026	Form 4: Pennell Sandra, Chief Financial Officer Bought 5,533 shares ($50K)
03 Mar 2026	Form 4: Michel Gerard J, Director Bought 11,200 shares ($100K)
18 Feb 2026	Form 4: Hoffman David L., GEN'L COUNSEL, CCO & SECY Granted 56,500 Stock Option (Right to Buy) · Granted 28,250 Restricted Stock Units
18 Feb 2026	Form 4: Muir Kevin, GM INTERVENTIONAL ONCOLOGY Granted 56,500 Stock Option (Right to Buy) · Granted 28,250 Restricted Stock Units
18 Feb 2026	Form 4: Pennell Sandra, Chief Financial Officer Granted 56,500 Stock Option (Right to Buy) · Granted 28,250 Restricted Stock Units
18 Feb 2026	Form 4: Vukovic Vojo, CHIEF MEDICAL OFFICER Granted 56,500 Stock Option (Right to Buy) · Granted 28,250 Restricted Stock Units
18 Feb 2026	Form 4: Rook Martha S., CHIEF OPERATING OFFICER Granted 56,500 Stock Option (Right to Buy) · Granted 28,250 Restricted Stock Units
18 Feb 2026	Form 4: Michel Gerard J, Director Granted 195,000 Stock Option (Right to Buy) · Granted 97,500 Restricted Stock Units
25 Nov 2025	Form 4: Sylvester John Richard, Director Bought 4,386 shares ($39K)
13 Nov 2025	Form 4: Michel Gerard J, Director Bought 11,500 shares ($98K)
13 Jun 2025	Form 4: Vukovic Vojo, CHIEF MEDICAL OFFICER Received 42,000 shares by exercise or conversion ($201K)
19 May 2025	Form 4: Sylvester John Richard, Director Granted 22,500 Stock Option (right to buy)
19 May 2025	Form 4: Salamon Steven A J, Director Granted 22,500 Stock Option (right to buy)
19 May 2025	Form 4: Czerepak Elizabeth, Director Granted 22,500 Stock Option (right to buy)

Comments